{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T12:36:27Z","timestamp":1793277387239,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,21]],"date-time":"2024-08-21T00:00:00Z","timestamp":1724198400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001858","name":"VINNOVA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013276","name":"Interreg Europe","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013276","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jhltonline.org","clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Heart and Lung Transplantation"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.healun.2024.08.014","type":"journal-article","created":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T04:48:54Z","timestamp":1724474934000},"page":"2018-2030","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Amniotic fluid-derived mesenchymal stem cells reduce inflammation and improve lung function following transplantation in a porcine model"],"prefix":"10.1016","volume":"43","author":[{"given":"Dag","family":"Edstr\u00f6m","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Niroomand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Stenlo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Broberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2393-452X","authenticated-orcid":false,"given":"Gabriel","family":"Hirdman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haider","family":"Ghaidan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Snejana","family":"Hyll\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leif","family":"Pierre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5222-6130","authenticated-orcid":false,"given":"Franziska","family":"Olm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4484-6473","authenticated-orcid":false,"given":"Sandra","family":"Lindstedt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.healun.2024.08.014_bib1","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.healun.2017.07.021","article-title":"Report of the ISHLT Working Group on Primary Lung Graft Dysfunction, part I: definition and grading-A 2016 Consensus Group statement of the International Society for Heart and Lung Transplantation","volume":"36","author":"Snell","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2024.08.014_bib2","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/S1053-2498(03)00096-2","article-title":"A review of lung transplant donor acceptability criteria","volume":"22","author":"Orens","year":"2003","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2024.08.014_bib3","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jtcvs.2010.09.009","article-title":"Short- and long-term outcomes of 1000 adult lung transplant recipients at a single center","volume":"141","author":"Kreisel","year":"2011","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.healun.2024.08.014_bib4","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1164\/rccm.201210-1865OC","article-title":"Clinical risk factors for primary graft dysfunction after lung transplantation","volume":"187","author":"Diamond","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.healun.2024.08.014_bib5","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.healun.2017.07.020","volume":"36","author":"Diamond","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2024.08.014_bib6","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1055\/s-0039-1683996","article-title":"Pathogenesis of acute respiratory distress syndrome","volume":"40","author":"Huppert","year":"2019","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.healun.2024.08.014_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0047559","article-title":"Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials","volume":"7","author":"Lalu","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.healun.2024.08.014_bib8","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S2213-2600(18)30418-1","article-title":"Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial","volume":"7","author":"Matthay","year":"2019","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.healun.2024.08.014_bib9","doi-asserted-by":"crossref","first-page":"S1329","DOI":"10.21037\/jtd.2019.04.22","article-title":"Cell therapy\u00a0for acute respiratory distress syndrome patients: the START study","volume":"11","author":"Cruz","year":"2019","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.healun.2024.08.014_bib10","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/sctm.20-0146","article-title":"Cell-based therapy to reduce mortality from COVID-19: systematic review and meta-analysis of human studies on acute respiratory distress syndrome","volume":"9","author":"Qu","year":"2020","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.healun.2024.08.014_bib11","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1164\/ajrccm.165.2.2011151","article-title":"Interleukin-8 release during early reperfusion predicts graft function in human lung transplantation","volume":"165","author":"De Perrot","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.healun.2024.08.014_bib12","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/nm.2736","article-title":"Mitochondrial transfer from bone-marrow-derived stromal cells to pulmonary alveoli protects against acute lung injury","volume":"18","author":"Islam","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.healun.2024.08.014_bib13","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1634\/stemcells.2006-0709","article-title":"Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow","volume":"25","author":"Baksh","year":"2007","journal-title":"Stem Cells"},{"key":"10.1016\/j.healun.2024.08.014_bib14","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/s13287-017-0582-6","article-title":"Term amniotic fluid: an unexploited reserve of mesenchymal stromal cells for reprogramming and potential cell therapy applications","volume":"8","author":"Moraghebi","year":"2017","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.healun.2024.08.014_bib15","doi-asserted-by":"crossref","first-page":"16357","DOI":"10.1073\/pnas.0907996106","article-title":"Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung","volume":"106","author":"Lee","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.healun.2024.08.014_bib16","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1164\/rccm.201206-0990OC","article-title":"Therapeutic effects of human mesenchymal stem cells in ex vivo human lungs injured with live bacteria","volume":"187","author":"Lee","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.healun.2024.08.014_bib17","doi-asserted-by":"crossref","first-page":"L809","DOI":"10.1152\/ajplung.00358.2013","article-title":"Clinical grade allogeneic human mesenchymal stem cells restore alveolar fluid clearance in human lungs rejected for transplantation","volume":"306","author":"McAuley","year":"2014","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.healun.2024.08.014_bib18","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.healun.2016.04.017","article-title":"Mesenchymal stem cell treatment is associated with decreased perfusate concentration of interleukin-8 during ex vivo perfusion of donor lungs after 18-hour preservation","volume":"35","author":"Mordant","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2024.08.014_bib19","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.healun.2019.07.006","article-title":"Mesenchymal stromal cell therapy during ex vivo lung perfusion ameliorates ischemia-reperfusion injury in lung transplantation","volume":"38","author":"Nakajima","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2024.08.014_bib20","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.omtm.2021.05.018","article-title":"Engineered mesenchymal stromal cell therapy during human lung ex vivo lung perfusion is compromised by acidic lung microenvironment","volume":"23","author":"Nykanen","year":"2021","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1016\/j.healun.2024.08.014_bib21","doi-asserted-by":"crossref","first-page":"L510","DOI":"10.1152\/ajplung.00524.2019","article-title":"Increased particle flow rate from airways precedes clinical signs of ARDS in a porcine model of LPS-induced acute lung injury","volume":"318","author":"Stenlo","year":"2020","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.healun.2024.08.014_bib22","doi-asserted-by":"crossref","first-page":"4173","DOI":"10.1038\/s41467-022-31811-5","article-title":"Reduction of primary graft dysfunction using cytokine adsorption during organ preservation and after lung transplantation","volume":"13","author":"Ghaidan","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.healun.2024.08.014_bib23","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1038\/s41596-018-0019-4","article-title":"Pig lung transplant survival model","volume":"13","author":"Mariscal","year":"2018","journal-title":"Nat Protoc"},{"key":"10.1016\/j.healun.2024.08.014_bib24","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1476-9255-2-8","article-title":"Mesenchymal stem cells avoid allogeneic rejection","volume":"2","author":"Ryan","year":"2005","journal-title":"J Inflamm"},{"key":"10.1016\/j.healun.2024.08.014_bib25","doi-asserted-by":"crossref","first-page":"L899","DOI":"10.1152\/ajplung.00338.2002","article-title":"Mechanisms of bacterial lipopolysaccharide-induced endothelial apoptosis","volume":"284","author":"Bannerman","year":"2003","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.healun.2024.08.014_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/S1465-3249(22)00212-2","article-title":"Lung tissue type selected amniotic fluid derived mesenchymal stem cells for treatment of bleomycin induced pulmonary fibrosis in a rat model","volume":"24","author":"Talts","year":"2022","journal-title":"Cytotherapy"},{"key":"10.1016\/j.healun.2024.08.014_bib27","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1634\/stemcells.22-5-675","article-title":"Study of telomere length reveals rapid aging of human marrow stromal cells following in vitro expansion","volume":"22","author":"Baxter","year":"2004","journal-title":"Stem Cells"},{"key":"10.1016\/j.healun.2024.08.014_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0002213","article-title":"Replicative senescence of mesenchymal stem cells: a continuous and organized process","volume":"3","author":"Wagner","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.healun.2024.08.014_bib29","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1089\/scd.2008.0253","article-title":"Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect","volume":"18","author":"Fischer","year":"2009","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.healun.2024.08.014_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.709225","article-title":"Persistency of mesenchymal stromal\/stem cells in lungs","volume":"9","author":"Ferrini","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.healun.2024.08.014_bib31","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13054-022-04287-4","article-title":"The safety and efficacy of mesenchymal stromal cells in ARDS: a meta-analysis of randomized controlled trials","volume":"27","author":"Wang","year":"2023","journal-title":"Crit Care"},{"key":"10.1016\/j.healun.2024.08.014_bib32","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.bj.2020.09.001","article-title":"Understanding the role of neutrophils in acute respiratory distress syndrome","volume":"44","author":"Yang","year":"2021","journal-title":"Biomed J"},{"key":"10.1016\/j.healun.2024.08.014_bib33","first-page":"3890","article-title":"MSC: immunoregulatory effects, roles on neutrophils and evolving clinical potentials","volume":"11","author":"Joel","year":"2019","journal-title":"Am J Transl Res"},{"key":"10.1016\/j.healun.2024.08.014_bib34","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1189\/jlb.1204697","article-title":"Myeloperoxidase: friend and foe","volume":"77","author":"Klebanoff","year":"2005","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.healun.2024.08.014_bib35","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.celrep.2014.06.044","article-title":"A myeloperoxidase-containing complex regulates neutrophil elastase release and actin dynamics during NETosis","volume":"8","author":"Metzler","year":"2014","journal-title":"Cell Rep"},{"key":"10.1016\/j.healun.2024.08.014_bib36","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1164\/rccm.201406-1086OC","article-title":"Neutrophil extracellular traps are pathogenic in primary graft dysfunction after lung transplantation","volume":"191","author":"Sayah","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.healun.2024.08.014_bib37","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.ajpath.2015.11.025","article-title":"Circulating extracellular histones are clinically relevant mediators of multiple organ injury","volume":"186","author":"Kawai","year":"2016","journal-title":"Am J Pathol"},{"key":"10.1016\/j.healun.2024.08.014_bib38","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.healun.2007.07.018","article-title":"Primary graft dysfunction and long-term pulmonary function after lung transplantation","volume":"26","author":"Whitson","year":"2007","journal-title":"J Heart Lung Transplant"}],"container-title":["The Journal of Heart and Lung Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105324982401800X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105324982401800X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T12:22:38Z","timestamp":1731586958000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S105324982401800X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":38,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S105324982401800X"],"URL":"https:\/\/doi.org\/10.1016\/j.healun.2024.08.014","relation":{},"ISSN":["1053-2498"],"issn-type":[{"value":"1053-2498","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Amniotic fluid-derived mesenchymal stem cells reduce inflammation and improve lung function following transplantation in a porcine model","name":"articletitle","label":"Article Title"},{"value":"The Journal of Heart and Lung Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.healun.2024.08.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of International Society for Heart and Lung Transplantation.","name":"copyright","label":"Copyright"}]}}